{"id":13153,"date":"2018-05-31T20:01:02","date_gmt":"2018-05-31T19:01:02","guid":{"rendered":"https:\/\/mileon.wordpress.com\/?p=13153"},"modified":"2018-05-31T20:01:02","modified_gmt":"2018-05-31T19:01:02","slug":"sindrome-antifosfolipido","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/maitines\/2018-05-31\/sindrome-antifosfolipido\/","title":{"rendered":"S\u00edndrome antifosfol\u00edpido."},"content":{"rendered":"<p style=\"text-align:justify;\">El martes 22 de Mayo el Dr. \u00c1ngel Mart\u00ednez, adjunto del S\u00ba de M. Interna, hace una puesta al d\u00eda sobre esta patolog\u00eda. Se citan los tres elementos clave: anticardiolipina,<img loading=\"lazy\" decoding=\"async\" class=\"  wp-image-13154 alignright\" src=\"https:\/\/mileon.files.wordpress.com\/2018\/05\/a04f02.jpg\" alt=\"a04f02\" width=\"327\" height=\"199\" \/> antibeta2-GP1 y anticoagulante l\u00fapico. Se citan los datos de prevalencia, imperfectos, en torno a 50 casos\/100.000 habitantes y la necesidad de combinar un diagn\u00f3stico cl\u00ednico y anal\u00edtico. Se analiza la relaci\u00f3n con diferentes patolog\u00edas: trombosis, ictus, enfermedades autoinmunes (s. t. LES), patolog\u00eda ginecol\u00f3gica, etc. Se describen tambi\u00e9n la fisiopatolog\u00eda y los m\u00e9todos de diagn\u00f3stico y cribado. Por \u00faltimo, se revisan las \u00faltimas recomendaciones de tratamiento.<\/p>\n<p>Pare ver la presentaci\u00f3n completa <a href=\"https:\/\/drive.google.com\/file\/d\/1tpOxVvDApzWJDvqL1VGTOGsUmKruTK3q\/view?usp=sharing\"><em><strong>pinchar AQU\u00cd<\/strong><\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El martes 22 de Mayo el Dr. \u00c1ngel Mart\u00ednez, adjunto del S\u00ba de M. Interna, hace una puesta al d\u00eda sobre esta patolog\u00eda. Se citan los tres elementos clave: anticardiolipina, antibeta2-GP1 y anticoagulante l\u00fapico. Se citan los datos de prevalencia, imperfectos, en torno a 50 casos\/100.000 habitantes y la necesidad de combinar un diagn\u00f3stico cl\u00ednico [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[715],"tags":[747],"class_list":["post-13153","post","type-post","status-publish","format-standard","hentry","category-maitines","tag-angel-martinez"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=13153"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13153\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=13153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=13153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=13153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}